image

A vial of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday Jan. 2, 2021. The UK has 530,000 doses available for rollout from Monday. (Gareth Fuller/Pool via AP)